Cryptisel 0.5 mg/ml oral solution for calves
Cryptisel 0.5 mg/ml oral solution for calves
Authorised
- Halofuginone lactate
Product identification
Medicine name:
Cryptisel 0.5 mg/ml oral solution for calves
Cryptisel 0,5 mg/ml šķīdums iekšķīgai lietošanai teļiem
Active substance:
- Halofuginone lactate
Target species:
-
Cattle (newborn calf)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Halofuginone lactate0.61/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Oral solution
Withdrawal period by route of administration:
-
Oral use
-
Cattle (newborn calf)
-
Meat and offal13day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QP51BX01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Industrial Veterinaria S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Industrial Veterinaria S.A.
- aniMedica GmbH
- aniMedica Herstellungs GmbH
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/DCP/20/0062
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0374/001
Concerned member states:
-
Austria
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 20/10/2025
Latvian (PDF)
Published on: 21/10/2025
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025
